"The two different types have fairly dramatically different clinical behaviors, " said Matthew Kulke, director of the carcinoid and pancreatic neuroendocrine tumor program at the Harvard-affiliated Dana-Farber Cancer Institute in Boston.
WSJ: Apple Co-Founder Steve Jobs's Rare Disease Ran Predictable Course